NXL New Plan Excel Realty Trust, I
New Plan Excel Realty Trust, I (NXL) is expected to report earnings on November 11, 2026, before the market open. The consensus earnings estimate is a loss of $2.70 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +1995.5% since its last earnings release on August 12, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About New Plan Excel Realty Trust, I
Nexalin Technology Inc. designs and develops neurostimulation products for mental health epidemic. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. Nexalin Technology Inc. is based in Houston, Texas.
Industry
REIT – Retail
Charts powered in part by Lightweight Charts™ by TradingView.